The Journal of Practical Medicine >
Carbapenem antibiotics combined with haemofiltration in patients with septic shock and the effect on serum lncRNA XIST and miRNA⁃130a
Received date: 2024-09-12
Online published: 2025-03-31
Objective To evaluate the application of carbapenem antibiotics in conjunction with hemofiltration for patients with septic shock and to analyze the impact on serum levels of lncRNA XIST and miRNA-130a. Methods A prospective study was conducted on 80 patients with septic shock treated at our hospital from August 2022 to January 2024. These patients were randomly divided into a control group and an experimental group， each comprising 40 cases. The control group received carbapenem antibiotics， while the experimental group received carbapenem antibiotics in combination with hemofiltration. The clinical outcomes of both groups were evaluated， and comparisons were made regarding their hemodynamic indices ［including cardiac output （CO）， central venous pressure （CVP）， and mean arterial pressure （MAP）］， immune function indices ［including interleukin-6 （IL-6）， C-reactive protein （CRP）， and tumor necrosis factor-alpha （TNF-α）］， oxygen metabolism indices ［including blood oxygen saturation （SaO2）， blood lactate （LAC）， and oxygenation index （PaO2/FiO2）］， as well as serum levels of lncRNA XIST and miRNA-130a expression. Results Following treatment， the levels of CO， CVP， MAP， SaO2， PaO2/FiO2， and miRNA-130a were significantly increased， whereas the levels of IL-6， CRP， TNF-α， LAC， and lncRNA XIST were significantly decreased compared to pre-treatment levels （all P < 0.05）. In comparison with the control group， the experimental group exhibited significantly higher levels of CO， CVP， MAP， and miRNA-130a， as well as significantly lower levels of IL-6， CRP， TNF-α， and lncRNA XIST （all P < 0.05）. The overall effective rate in the experimental group was significantly higher than that in the control group （χ 2 = 4.501， P < 0.05）， while no significant difference was observed in the incidence of adverse reactions between the two groups （χ 2 = 0.180， P > 0.05）. Conclusion Carbapenem antibiotics and hemofiltration therapy can alleviate the symptoms of septic shock patients by downregulating lncRNA XIST expression， upregulating miRNA-130a expression， modulating inflammatory factors， enhancing oxygen metabolism indices， and maintaining hemodynamic stability.
Wenchi ZENG , Yuanli ZHANG , Mingdi CHEN , Hongyu DONG , Jinzhao. BAI . Carbapenem antibiotics combined with haemofiltration in patients with septic shock and the effect on serum lncRNA XIST and miRNA⁃130a[J]. The Journal of Practical Medicine, 2025 , 41(6) : 866 -871 . DOI: 10.3969/j.issn.1006-5725.2025.06.014
| 1 | TANG D， WANG H， BILLIAR T R， et al. Emerging mechanisms of immunocoagulation in sepsis and septic shock［J］. Trends Immunol， 2021， 42（6）： 508-522. doi:10.1016/j.it.2021.04.001 |
| 2 | CARRARA M， FERRARIO M， BOLLEN PINTO B， et al. The autonomic nervous system in septic shock and its role as a future therapeutic target：A narrative review［J］. Ann Intensive Care， 2021， 11（1）： 80-82. doi:10.1186/s13613-021-00869-7 |
| 3 | ASNER S A， DESGRANGES F， SCHRIJVER I T， et al. Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock［J］. J Infect， 2021， 82（5）： 125-134. doi:10.1016/j.jinf.2021.03.003 |
| 4 | CHU L， LI G， YU Y， et al. Clinical effects of hemoperfusion combined with pulse high-volume hemofiltration on septic shock［J］. Medicine， 2020， 99（9）： 1-5. doi:10.1097/md.0000000000019058 |
| 5 | 安阳， 童朝辉， 张睢扬， 等. 美罗培南持续泵入治疗ICU老年脓毒血症患者的机制探讨［J］. 实用医学杂志， 2021， 37（6）： 726-729，734. |
| 6 | ZHENG P， PAN P， FENG T， et al. High-throughput sequencing and exploration of the lncRNA-circRNA-miRNA-mRNA network in type 2 diabetes mellitus［J］. Biomed Res Int， 2020， 20（20）： 816-825. |
| 7 | 姜平， 郭哲， 梁殿迅， 等. 长链非编码RNA X失活特异转录物调控miR-340-5p对卵巢癌细胞上皮间质转化的影响［J］. 实用医学杂志， 2023， 39（1）： 41-47. |
| 8 | SINGER M， DEUTSCHMAN C S， SEYMOUR C W， et al. The third international consensus definitions for sepsis and septic shock（Sepsis-3）［J］. JAMA， 2016， 315（8）： 801-810. |
| 9 | 《抗菌药物临床应用指导原则》修订工作组. 抗菌药物临床应用指导原则（2015版）［M］. 北京：人民卫生出版社， 2015. |
| 10 | 吴海艳， 孔菲菲， 刘玉飞， 等. 乌司他丁辅助常规治疗改善脓毒症患者肝肾功能的作用机制研究［J］. 中国全科医学， 2023， 26（S1）： 64-66. |
| 11 | 董妍， 李春， 杨志旭， 等. 通腑泻肺汤联合大剂量沐舒坦对脓毒症相关ARDS患者的影响［J］. 时珍国医国药， 2021， 32（12）： 2951-2953. |
| 12 | LU Z， JING Y， MIN X， et al. Severe cutaneous adverse reactions due to antibiotics therapy： A pharmacovigilance analysis of FDA adverse event reporting system events.［J］. Expert Opin Drug Saf， 2023. doi： 10.1080/14740338.2023.2278685 . Epub ahead of print. |
| 13 | ZENG Z， ZOU K， QING C， et al. Predicting mortality in acute kidney injury patients undergoing continuous renal replacement therapy using a visualization model： A retrospective study［J］. Front Physiol， 2022， 13： 964312. doi:10.3389/fphys.2022.964312 |
| 14 | MONARD C， ABRAHAM P， SCHNEIDER A， et al. New targets for extracorporeal blood purification therapies in sepsis［J］. Blood Purif， 2023， 52（1）： 1-7. doi:10.1159/000524973 |
| 15 | KOTHEKAR A T， DIVATIA J V， MYATRA S N， et al. Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock： Implications for empirical therapy against Gram-negative bacteria［J］. Ann Intensive Care， 2020， 10（1）： 2-9. doi:10.1186/s13613-019-0622-8 |
| 16 | SCHWARTZ Y， HANUKA A， ABRAM B T， et al. Effectiveness of serial C-reactive protein （CRP） measurements in hospitalized patients with blood stream infection［J］. Harefuah， 2024， 163（11）： 699-704. |
| 17 | KANG S， KISHIMOTO T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms［J］. Exp Mol Me， 2021， 53（7）： 1116-1123. doi:10.1038/s12276-021-00649-0 |
| 18 | LONG Y J， QIN Y J， QI J X， et al. Pharmacological effects of koumine on acute lung injury in septic mice： From in vivo experiments and network pharmacology studies［J］. Biochem Biophys Res Commun， 2024， 739： 150968. doi:10.1016/j.bbrc.2024.150968 |
| 19 | ZHANG H， LIU C， CAO A， et al. Clinical value of CVP+VIVC in predicting fluid resuscitation in patients with septic shock［J］. Afr Health Sci， 2023， 23（3）： 449-459. doi:10.4314/ahs.v23i3.52 |
| 20 | CAVE D G， BAUTISTA M J， MUSTAFA K， et al. Cardiac output monitoring in children：A review［J］. Arch Dis Child， 2023， 108（12）： 949-955. doi:10.1136/archdischild-2022-325030 |
| 21 | LUO Y， LI L， CHEN X， et al. Effects of lactate in immunosuppression and inflammation：Progress and prospects［J］. Int Rev Immunol， 2022， 41（1）： 19-29. doi:10.1080/08830185.2021.1974856 |
| 22 | GAN Y， TIAN X， YAO H， et al. Ozone Improves Oxygenation and Offers Organ Protection after Autologous Blood Transfusion in a Simulated Carbon Dioxide Pneumoperitoneal Environment in a Rabbit Hemorrhagic Shock Model［J］. Transfus Med Hemother， 2023， 51（3）：164-174. doi:10.1159/000527934 |
| 23 | WANG W L， MIN L， QIU X Y， et al. Biological function of long non-coding RNA （lncRNA） XIST［J］. Front Cell Dev Biol， 2021， 9： 645647. doi:10.3389/fcell.2021.645647 |
| 24 | SONG X， LI L， ZHAO Y， et al. Down-regulation of long non-coding RNA XIST aggravates sepsis-induced lung injury by regulating miR-16-5p［J］. Hum cell， 2021， 34（5）： 1335-1345. doi:10.1007/s13577-021-00542-y |
| 25 | WANG X， LI X L， QIN L J. The lncRNA XIST/miR-150-5p/c-Fos axis regulates sepsis-induced myocardial injury via TXNIP-modulated pyroptosis［J］. Lab Invest， 2021， 101（9）： 1118-1129. doi:10.1038/s41374-021-00607-4 |
| 26 | GHAFOURI-FARD S， KHOSHBAKHT T， HUSSEN B M， et al. Regulatory role of non-coding RNAs on immune responses during sepsis［J］. Front Immunol， 2021， 12： 798713. doi:10.3389/fimmu.2021.798713 |
/
| 〈 |
|
〉 |